Glycation products and the pathogenesis of diabetic complications

Keyphrases

• Aminoguanidine 100%
• Diabetes Complications 100%
• Glycation Products 100%
• Thrombosis 50%
• Pre-diabetes (pre-DM) 50%
• Pharmacological Inhibitors 50%
• Cell Function 50%
• Protein-DNA Complex 50%
• Macromolecules 50%
• Endothelial Cells 50%
• Glucose Homeostasis 50%
• Cell Adhesion 50%
• Cell Growth 50%
• Diabetic Neuropathy 50%
• Modified Proteins 50%
• Type IV Collagen 50%
• Overproduction 50%
• Qualitative Change 50%
• Quantitative Change 50%
• Nuclear Proteins 50%
• Potential Therapeutics 50%
• Cell Matrix 50%
• Specific Receptor 50%
• Diabetic Retinopathy 50%
• Laminin 50%
• Glucose Concentration 50%
• Macrophage Cells 50%
• Diabetic Nephropathy 50%
• Adhesion Growth 50%
• Extracellular Matrix Protein 1 (ECM1) 50%
• Therapeutic Role 50%
• AGE Formation 50%
• Vasoconstriction 50%
• Vitronectin 50%
• Matrix Accumulation 50%
• Hyperglycemic Memory 50%
• AGE Inhibitors 50%
• Long-lived 50%
• Normal Glucose 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetic Complication 100%
• Glucose 100%
• Pathogenesis 100%
• Aminoguanidine 66%
• Receptor 33%
• Thrombosis 33%
• Diabetes Mellitus 33%
• Deoxyribonucleoprotein 33%
• Diabetic Nephropathy 33%
• Nuclear Protein 33%
• Collagen Type 4 33%
• Diabetic Retinopathy 33%
• Diabetic Neuropathy 33%
• Vitronectin 33%
• Laminin 33%

Neuroscience

• Diabetes Mellitus 100%
• Glucose 100%
• Extracellular Matrix 66%
• Macrophage 33%
• In Vivo 33%
• Diabetic Neuropathy 33%
• Cell Adhesion 33%
• Cell Growth 33%
• Cell Function 33%
• Diabetic Retinopathy 33%
• Nuclear Protein 33%
• Collagen Type 4 33%
• Vitronectin 33%
• Deoxyribonucleoprotein 33%
• Receptor 33%
• Laminin 33%